Press release
BKV Infection Therapeutics Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight
DelveInsight's "BK Virus Infection Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of BK Virus Infection, historical and forecasted epidemiology as well as the BK Virus Infection market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.Unlock key insights into the BKV Infection Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ BKV Infection Market Size [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the BKV Infection Market Report
* On November 1, 2024, AiCuris Anti-infective Cures initiated its first-in-human Phase I trial of AIC468, an antisense oligonucleotide aimed at treating BK virus (BKV) infections in kidney transplant (KT) recipients. This study will assess the tolerability, safety, and pharmacokinetics of AIC468 in healthy participants. Conducted in Germany, the double-blind, randomized, placebo-controlled trial will involve 72 healthy volunteers aged 18 to 64.
* BK Polyomavirus reactivation can manifest as viruria in 30-40%, viremia in 10-20%, and BK polyomavirus-associated nephropathy (BKPyVAN) in 1-10% of recipients.
* Genotype I constitutes approximately 80% of the total cases, making it the most prevalent, followed by genotype IV, which accounts for around 15% of the total cases.
* Hemorrhagic cystitis occurs in up to 70% of allogeneic bone marrow transplant patients, while the detection rate of BK virus after transplant ranges from 50% to 80%.
* The leading BKV Infection Companies such as AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics , and others.
* Promising BKV Infection Therapies such as MAU868, Ciclosporin and Mycophenolate-mofetil, and others.
Stay ahead in the competitive landscape of the BKV Infection Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ BKV Infection Treatment Market Size [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
BKV Infection Epidemiology Segmentation in the 7MM
* Total Number of Kidney Transplant Cases, Hematopoietic Stem Cell Transplant (HSCT)
* Total Incident Cases of BKV Infections
* Total Cases of BKV Infection by Viral Genotype
* Treatable Cases of BKV Infection
Download the report to understand which factors are driving BKV Infection epidemiology trends @ BKV Infection Prevalence [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
BK Virus Infection Emerging Drugs
* AntiBKV: Memo Therapeutics
AntiBKV is a BK virus-neutralizing antibody isolated from humans for the treatment of BK virus infection after renal transplantation. The antibody has the properties such as highly virus neutralizing, Pico-molar affinity and optimal safety profile due to human origin (negative/positive selection) and known viral target. The product has received Fast-track Designation from the US FDA in May 2023.
* MAU868: Vera Therapeutics
MAU868 is a potent, human monoclonal antibody (immunoglobulin G, IgG1/ isotype subclass) that neutralizes all four BKV serotypes. It recognizes a conformational epitope on the viral capsid protein, VP1, which is responsible for binding to and the infection of new cells. Vera holds an exclusive worldwide license from Amplyx Pharmaceuticals, a wholly owned subsidiary of Pfizer for the development and commercialization of MAU868 in all indications. Final results from the Phase II clinical trial of MAU868 versus placebo showed that MAU868 was well tolerated and demonstrated clinically meaningful reductions in BK antiviral activity through 36 weeks in kidney transplant patients with BK viremia.
BK Virus Infection Market Outlook
Key BK Virus Infection companies such as Memo Therapeutics, Vera Therapeutics, SymBio Pharmaceuticals, and others are evaluating their lead candidates in different stages of clinical development, respectively. They aim to investigate their products for the treatment of BK Virus (BKV) Infection. Adjusting the dosing regimen of immunosuppressants, such as minimizing calcineurin inhibitors and incorporating mTOR inhibitors and leflunomide is mostly used for the treatment of BKV infection. BK-specific T-cell therapy and vaccines are emerging options for the management and prevention of BKV infection. Emerging studies may shape the future of BKV infection management by prioritizing treatment efficacy while minimizing adverse effects, ultimately optimizing graft and patient survival.
Discover the future of BKV Infection Treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ BKV Infection Market Drivers and Barriers [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the BKV Infection Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* BKV Infection Companies- AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics , and others.
* BKV Infection Therapies- MAU868, Ciclosporin and Mycophenolate-mofetil , and others.
* BKV Infection Therapeutic Assessment: BKV Infection Current Marketed and BKV Infection Emerging Therapies
* BKV Infection Market Dynamics: BKV Infection market drivers and BKV Infection market barriers
* BKV Infection Unmet Needs, KOL's views, Analyst's views, BKV Infection Market Access and Reimbursement
Explore the dynamics of the BKV Infection Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ BKV Infection Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Executive Summary of BK virus (BKV) Infection
3. Competitive Intelligence Analysis for BK virus (BKV) Infection
4. BK virus (BKV) Infection: Market Overview at a Glance
5. BK virus (BKV) Infection: Disease Background and Overview
6. Patient Journey
7. BK virus (BKV) Infection Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. BK virus (BKV) Infection Unmet Needs
10. Key Endpoints of BK virus (BKV) Infection Treatment
11. BK virus (BKV) Infection Marketed Products
12. BK virus (BKV) Infection Emerging Therapies
13. BK virus (BKV) Infection: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of BK virus (BKV) Infection
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bkv-infection-therapeutics-market-size-in-the-7mm-is-expected-to-grow-by-2034-estimates-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BKV Infection Therapeutics Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight here
News-ID: 3825926 • Views: …
More Releases from ABNewswire

SourceAudio Launches Mood Magic: Functional Music Developed to Support Better Le …
SourceAudio, the music industry's most widely adopted sync platform, today announced the launch of Mood Magic, a purpose-built music initiative designed to support and empower students with dynamic, emotionally attuned music for modern K-6 learning. Mood Magic is grounded in evidence-based research and aligned with daily K-6 routines to help all learners, including neurodivergent students, stay focused, calm, energized, and emotionally regulated in all learning environments.
SourceAudio, the music industry's most…

Mark Ford and the Rangers Release Southern Ohio Christmas: A Timeless Country Ho …
Nashville, TN - As autumn settles across Southern Ohio's rolling hills and valleys and the first hints of winter touch the countryside, Mark Ford and The Rangers welcome the season with the release of their highly anticipated holiday album, Southern Ohio Christmas. More than a collection of seasonal songs, this record captures the spirit of a holiday in the heartland. It offers listeners an authentic, heartfelt alternative to the commercial…

CartonCloud Transforms E-Commerce Logistics with Next-Generation 3PL Software
The global e-commerce industry has experienced rapid growth over the last decade, with customer expectations evolving alongside it. Shoppers today demand faster delivery, transparent tracking, and seamless order fulfillment. This shift has created enormous pressure on businesses, especially logistics providers, who are tasked with managing complex supply chains across multiple platforms.
For third-party logistics (3PL) providers, staying competitive in this environment requires more than just manpower and trucks-it demands intelligent technology.…

Unlock Discounted Cleveland Cavaliers NBA Tickets with CITY10 Code at CapitalCit …
Save big on Cleveland Cavaliers NBA tickets for the 2025-26 season! Use promo code CITY10 at CapitalCityTickets.com to unlock exclusive discounts. Find the best seats at Rocket Mortgage FieldHouse, compare ticket options, and secure your spot to watch the Cavs live. Don't miss your chance to enjoy top NBA action while saving-grab discounted tickets today and cheer courtside without overspending!
As the 2025-26 NBA season tips off, the Cleveland Cavaliers are…
More Releases for BKV
BK Virus (BKV) Infection Market Deep Research Report with Forecast to 2032 | All …
The BK Virus (BKV) infection market is estimated to be valued at USD 48.3 Mn in 2025 and is expected to reach USD 559.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 41.9% from 2025 to 2032.
The BK Virus (BKV) Infection Market research report not only assists newly entered businesses but also assists businesses of all levels, shapes, scope, experience levels and sizes. This report also…
BK Virus (BKV) Infection Market Projected CAGR 41.7%, Growth Insights Industry T …
According to a new report published by CoherentMI The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024 and is expected to reach USD 389 Mn by 2031, growing at a compound annual growth rate (CAGR) of 41.7% from 2024 to 2031.
The Global BK Virus (BKV) Infection Market has recently been analyzed and explored by CoherentMI in their latest market research report.…
BK Virus (BKV) Infection Market Industry Overview, Size, and Growth Insights Rep …
A new Report by CoherentMI Market Reports, titled "BK Virus (BKV) Infection Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the BK Virus (BKV) Infection market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024…
BK virus (BKV) Infection Market to witness growth by 2032, estimates DelveInsigh …
(Albany, USA) DelveInsight's "BK virus (BKV) Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of BK virus (BKV) Infection, historical and forecasted epidemiology as well as the BK virus (BKV) Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The BK virus (BKV) Infection market report provides current treatment practices, emerging drugs, the market share of the individual…
BK virus (BKV) Infection Pipeline Drugs and Companies Insight Report (2022): Ana …
BK virus (BKV) Infection pipeline constitutes 4+ key companies continuously working towards developing 4+ BK virus (BKV) Infection treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
BK virus (BKV) Infection Overview
BK virus (BKV) Infection- The BK virus was first isolated from the urine of a renal transplant recipient with ureteric stenosis in1971. BK virus is one of 13 known polyomaviruses.…
Advertising Agencie Service Market Statistical Forecast, Trade Analysis 2022 -WP …
The Advertising Agencie Service report is an in-depth examination of the global Advertising Agencie Service's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Advertising Agencie Service industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Advertising Agencie Service analysis takes into account a number of aspects, including a country's population and business cycles, as…